ERIS LIFESCIENCES
|
The Current P/S Ratio of ERIS LIFESCIENCES is 7.99.
Share Price | ₹1,466.8 | Nov 27,2024 |
Market Cap | ₹19,962.5 Cr | |
Sales-TTM | ₹2,498.1 Cr | TTM-Consolidated Results |
Price/Sales | 7.99x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ERIS LIFESCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,962.5 Cr] as on Nov 27,2024
(/) Sales [ ₹2,498.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.99x ]
Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay '7.99 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ERIS LIFESCIENCES !
The chart below summarizes the trend in P/S Ratio of ERIS LIFESCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of ERIS LIFESCIENCES
PS Ratio Performance Analysis for ERIS LIFESCIENCES
- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.74x.
- ERIS LIFESCIENCES 's operated at median p/e ratio of 5.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2022 at 6.95x.
- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 4.62x.
How does ERIS LIFESCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ERIS LIFESCIENCES | 2,498.1 | 7.99 | 19,962.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.34 | 419,764.0 |
CIPLA LTD | 26,512.0 | 4.54 | 120,459.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.33 | 100,168.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.45 | 95,662.7 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.49 | 159,306.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.29 | 102,379.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.72 | 109,086.0 |
LUPIN LTD | 21,431.3 | 4.27 | 91,526.9 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.35 | 71,087.2 |
ABBOTT INDIA LTD | 6,066.1 | 9.64 | 58,446.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ERIS LIFESCIENCES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.35x |
Max industry PS | 18.49x |
Median industry PS | 7.99x |
Average industry PS | 7.49x |
You may also like the below Video Courses